LOS ANGELES & MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Phase 1 trial data showing use of live biotherapeutic CBM588 and immunotherapy medicine can improve survival in patients with metastatic kidney cancer
News Ticker
- [ October 5, 2026 ] Biomedical Technician – GMP Manufacturing – West Hollywood, CA 90048 Los Angeles Biotech Jobs
- [ October 2, 2026 ] Associate Research Specialist / Dr. Tsai – Los Angeles, CA Los Angeles Biotech Jobs
- [ October 2, 2026 ] Exobiosphere to Become the First Commercial Customer of Outpost’s New Space Factories, Bringing Microgravity Drug Discovery to Orbit and Back Los Angeles Biotech News
- [ October 2, 2026 ] FDA to Highlight Aging, Longevity Medicine in Planned FARS Update Los Angeles Biotech News
- [ October 2, 2026 ] New Research on Postpartum Depression vs. Depression: What Brain Imaging Reveals Los Angeles Biotech News
Copyright © 2026 Biotech Networks, LLC
